Westgeest AA - Search Results

1

An improved incubation apparatus for Western blots used for the detection of antinuclear antibodies.

Westgeest AA, Bons JC, Van den Brink HG, Aarden LA, Smeenk RJ. Westgeest AA, et al. J Immunol Methods. 1986 Dec 24;95(2):283-8. doi: 10.1016/0022-1759(86)90417-5. J Immunol Methods. 1986. PMID: 3794348

2

Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting.

Westgeest AA, van den Brink HG, de Jong J, Swaak AJ, Smeenk RJ. Westgeest AA, et al. Rheumatol Int. 1987;7(2):77-82. doi: 10.1007/BF00270311. Rheumatol Int. 1987. PMID: 3497422

3

Routine testing for antinuclear antibodies: a comparison of immunofluorescence, counterimmunoelectrophoresis and immunoblotting.

Westgeest AA, van den Brink HG, de Jong J, Swaak AJ, Smeenk RJ. Westgeest AA, et al. J Autoimmun. 1988 Apr;1(2):159-70. doi: 10.1016/0896-8411(88)90023-6. J Autoimmun. 1988. PMID: 3075460

4

Reaction patterns of monoclonal antibodies to DNA.

Smeenk RJ, Brinkman K, van den Brink HG, Westgeest AA. Smeenk RJ, et al. Among authors: westgeest aa. J Immunol. 1988 Jun 1;140(11):3786-92. J Immunol. 1988. PMID: 2453555

5

Technical aspects of ANA determination.

Aarden L, Westgeest A, Smeenk R. Aarden L, et al. Scand J Rheumatol Suppl. 1985;56:65-71. doi: 10.3109/03009748509102064. Scand J Rheumatol Suppl. 1985. PMID: 3890153 No abstract available.

6

Immunogenetic heterogeneity of seronegative rheumatoid arthritis and the antiperinuclear factor.

Boerbooms AM, Westgeest AA, Reekers P, van de Putte LB. Boerbooms AM, et al. Among authors: westgeest aa. Ann Rheum Dis. 1990 Jan;49(1):15-7. doi: 10.1136/ard.49.1.15. Ann Rheum Dis. 1990. PMID: 2310221 Free PMC article.

7

Antiperinuclear factor, a rheumatoid arthritis specific autoantibody: its relation to Epstein-Barr virus.

Westgeest AA, van Loon AM, van der Logt JT, van de Putte LB, Boerbooms AM. Westgeest AA, et al. J Rheumatol. 1989 May;16(5):626-30. J Rheumatol. 1989. PMID: 2547060

8

Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.

Westgeest AA, Boerbooms AM, Jongmans M, Vandenbroucke JP, Vierwinden G, van de Putte LB. Westgeest AA, et al. J Rheumatol. 1987 Oct;14(5):893-7. J Rheumatol. 1987. PMID: 3501470

9

Methotrexate in refractory rheumatoid arthritis.

Boerbooms AM, Jeurissen ME, Westgeest AA, Theunisse H, Van de Putte LB. Boerbooms AM, et al. Among authors: westgeest aa. Clin Rheumatol. 1988 Jun;7(2):249-56. doi: 10.1007/BF02204463. Clin Rheumatol. 1988. PMID: 3416568

10

The influence of serum dilution on findings of antiperinuclear factor prevalence in rheumatoid arthritis.

Westgeest AA, Boerbooms AM, van de Putte LB. Westgeest AA, et al. Arthritis Rheum. 1990 May;33(5):759-60. doi: 10.1002/art.1780330524. Arthritis Rheum. 1990. PMID: 2189418 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page